Chongling Hu

机构：University of Science and Technology of China, Chongqing University, Chinese Academy of Sciences, Beijing University of Technology, Wuhan Institute of Virology, Chongqing Cancer Hospital, Children's Hospital of Chongqing Medical University, University of Chinese Academy of Sciences, Chongqing Medical University · ORCID：0000-0002-2129-6926

发表论文 30 篇 · 总被引 144 次 · h-index 6

代表论文

MSCs can be a double-edged sword in tumorigenesis (2022 · Frontiers in Oncology · 被引 29)
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians (2021 · UNC Libraries · 被引 19)
Clinical characteristics and outcomes of newly diagnosed patients with HIV ‐associated aggressive B‐cell NHL in China (2022 · Journal of Cellular and Molecular Medicine · 被引 17)
Orelabrutinib, Rituximab, and High-Dose Methotrexate (HD-MTX) in Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL): A Retrospective Analysis on Efficacy, Safety, and Biomarker (2022 · Blood · 被引 7)
Antibody responses to SARS‐CoV‐2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study (2023 · Journal of Medical Virology · 被引 4)
Rituximab, high-dose methotrexate plus orelabrutinib as induction therapy in newly diagnosed primary central nervous system lymphoma (2025 · Leukemia · 被引 3)